Multiplex human Malaria array: Quantifying antigens for malaria rapid diagnostics

Jang I.K.; Tyler A.; Lyman C.; Rek J.C.; Arinaitwe E.; Adrama H.; Murphy M.; Imwong M.; Proux S.; Haohankhunnatham W.; Barney R.; Rashid A.; Kalnoky M.; Kahn M.; Golden A.; Nosten F.; Greenhouse B.; Gamboa D.; Domingo G.J. · American Journal of Tropical Medicine and Hygiene (2020) · DOI: 10.4269/ajtmh.19-0763

Resumen

Malaria antigen detection through rapid diagnostic tests (RDTs) is widely used to diagnose malaria and estimate prevalence. To support more sensitive next-generationRDTdevelopment and screen asymptomatic malaria,we developed and evaluated the Q-Plex™ Human Malaria Array (Quansys Biosciences, Logan, UT), which quantifies the antigens commonly used in RDTs-Plasmodium falciparum-specific histidine-rich protein 2 (HRP2), P. falciparumspecific lactate dehydrogenase (Pf LDH), Plasmodium vivax-specific LDH (Pv LDH), and Pan malaria lactate dehydrogenase (Pan LDH), and human C-reactive protein (CRP), a biomarker of severity in malaria. At threshold levels yielding 99.5% or more diagnostic specificity, diagnostic sensitivities against polymerase chain reaction-confirmed malaria for HRP2, Pf LDH, Pv LDH, and Pan LDH were 92.7%, 71.5%, 46.1%, and 83.8%, respectively. P. falciparum culture strains and samples from Peru indicated that HRP2 and Pf LDH combined improves detection of P. falciparum parasites with hrp2 and hrp3 deletions. This array can be used for antigen-based malaria screening and detecting hrp2/3 deletion mutants of P. falciparum.

Instituciones: Universidad Peruana Cayetano Heredia